August 26, 2016 2:54 PM ET

Healthcare Providers and Services

Company Overview of Dana-Farber Cancer Institute, Inc.

Company Overview

Dana-Farber Cancer Institute, Inc. provides cancer treatment and research services for adults and children in the United States. It offers services in the areas of blood, breast, cutaneous/skin, gastrointestinal, genitourinary, gynecological, head and neck, hematology, melanoma, neuro-oncology, sarcoma, and thoracic cancer aspects; and cancer genetics and prevention services. The company also provides services for blood disorders, brain tumors, stem cell transplantations, hematologic malignancies, and solid tumors. It offers its services through its cancer centers. Dana-Farber Cancer Institute, Inc. was formerly known as Sidney Farber Cancer Center and changed its name in 1983. The company w...

450 Brookline Avenue

Boston, MA 02215-5450

United States

Founded in 1947

Phone:

617-632-3000

Fax:

617-632-3057

Key Executives for Dana-Farber Cancer Institute, Inc.

Chief Executive Officer and President
Chief Financial Officer and Senior Vice President for Finance
Chief Operating Officer and Executive Vice President
Age: 65
General Counsel, Senior Vice President and Assistant Secretary
Compensation as of Fiscal Year 2016.

Dana-Farber Cancer Institute, Inc. Key Developments

Dana-Farber Cancer Institute Appoints Larry Lucchino as Chairman of Jimmy Fund

Dana-Farber Cancer Institute appointed Larry Lucchino as Chairman of the Jimmy Fund. For the last 14 years, he has been president/CEO of the Boston Red Sox, and, after the 2015 season, was named Boston Red Sox President/CEO Emeritus. As Chairman of the Jimmy Fund, Lucchino, who is now also Chairman of the Pawtucket Red Sox, will be the lead ambassador and public spokesperson for the Jimmy Fund to strengthen relationships with the corporate community and professional sports teams, to strategize on policy and fundraising initiatives, and to recognize the many passionate donors and event participants. Lucchino will help increase awareness of the importance of philanthropic support for Dana-Farber and highlight the breakthroughs and milestones Dana-Farber doctors and researchers have achieved toward finding cures and treatments for cancer as a result of Jimmy Fund support.

Dana-Farber Cancer Institute, Inc. Presents at Sachs Associates 2nd Annual Immune-Oncology BD&L and Investment Forum, Jun-03-2016 01:50 PM

Dana-Farber Cancer Institute, Inc. Presents at Sachs Associates 2nd Annual Immune-Oncology BD&L and Investment Forum, Jun-03-2016 01:50 PM. Venue: Hyatt Chicago Magnificent Mile, 633 North Saint Clair Street, Chicago, IL 60611, United States. Speakers: Gary Sclar, Chief Research Business Development Officer.

Dana-Farber Cancer Institute Announces Executive Changes

Dana-Farber Cancer Institute annolunced that Laurie H. Glimcher, MD, has been named the next president and CEO of the Dana-Farber Cancer Institute. Glimcher is currently the Stephen and Suzanne Weiss Dean of the Medical College at Weill Cornell Medicine in New York City, where she is also professor of medicine and provost for medical affairs at Cornell University. Glimcher will begin at Dana-Farber in January, 2016 and current President Edward J. Benz, Jr., MD, has agreed to remain as president until her arrival at the Institute. She will also be a professor of medicine at the Harvard Medical School. Prior to joining Weill Cornell Medicine, Glimcher was the Irene Heinz Given Professor of Immunology at the Harvard School of Public Health, and Professor of Medicine at Harvard Medical School, where she headed one of the top immunology programs in the world. Glimcher, a renowned immunologist and current dean of Cornell University's medical college, Weill Cornell Medicine, will replace Dr. Edward Benz, who is retiring after 16 years in the role. Benz will remain in the position until Glimcher arrives in January.

Similar Private Companies By Industry

Company Name Region
@ Home Medical, Inc. United States
@home approach, llc United States
@Home Care United States
1011 E. Pecan Grove Road, LLC United States
1125 Sir Francis Drake Boulevard Operating Company, Llc United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Dana-Farber Cancer Institute, Inc., please visit www.dana-farber.org. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.